A Functional Approach to Preventing Reversing Osteopenia and Osteoporosis

How targeted nutrition, strategic supplementation, peptide therapy, and hormonal support can meaningfully restore bone mineral density

A diagnosis of osteopenia doesn't have to be a one-way road. Unlike its more advanced counterpart osteoporosis, osteopenia sits in a window of real opportunity — a stage at which targeted, evidence-informed interventions can halt bone loss, stimulate new bone formation, and in many cases, meaningfully restore density.

In functional medicine, we look at bone health not as a calcium problem, but as a systems problem — involving hormones, gut health, nutrient status, mechanical loading, and the signaling molecules that govern the constant cycle of bone resorption and formation. Here's what the evidence supports.

The foundation: movement and mechanical load

Before any supplement or protocol, it's worth stating clearly: weight-bearing and resistance exercise is the single most powerful stimulus for bone remodeling. Bone is living tissue that responds to mechanical stress by laying down new mineral. Aim for three to four sessions per week combining weight-bearing activity — walking, hiking, dancing — with progressive resistance training. This is non-negotiable as a foundation.

 

Eat your calcium — why supplements fall short

For decades, the conventional advice for osteopenia was simple: take a calcium supplement. We now know this approach is not only inadequate but potentially harmful. Dietary calcium from whole foods is meaningfully superior to supplemental calcium for BMD — and oral calcium supplementation at the doses typically recommended carries real risks that are not trivial.

 

Why oral calcium supplementation is not recommended

When calcium is consumed in large, isolated doses — as in a supplement — the body receives a sudden flood of calcium it cannot fully direct into bone. Without precise co-factor balance (particularly K2 and magnesium), this excess calcium can deposit in soft tissues rather than bone, contributing to serious downstream consequences.

Kidney stones

Excess supplemental calcium raises urinary calcium levels, significantly increasing the risk of calcium oxalate and calcium phosphate kidney stones — the most common kidney stone types.

Arterial calcification

Calcium deposited in arterial walls contributes to calcified atherosclerotic plaques, stiffening vessels and raising cardiovascular risk. Multiple large studies link high-dose calcium supplements to increased heart attack risk.

Soft tissue deposits

Calcium can accumulate in joints, tendons, and breast tissue when the body's routing mechanisms are overwhelmed, contributing to calcific tendinitis and other benign but painful conditions.

Poor bone uptake

Ironically, supplemental calcium may not meaningfully improve BMD. Without the full matrix of food co-factors, absorption and bone deposition are far less efficient than from dietary sources.

"The goal is not to flood the body with calcium — it's to build a diet that delivers it in the way the body is designed to receive it."

Whole-food calcium arrives packaged with naturally occurring co-factors, proteins, minerals, and signaling compounds that guide its absorption and deposition correctly. Prioritize these calcium-rich foods:

Sardines & anchovies

• Eaten with the bones
• Among the richest whole-food calcium sources; also deliver omega-3s and vitamin D in the same package

Dairy & fermented dairy

• Yogurt, kefir, aged cheese
• High bioavailability; kefir also supports gut microbiome integrity for broader nutrient absorption

Dark leafy greens

Kale, bok choy, broccoli

• Also rich in vitamin K1, which supports bone mineralization pathways

Almonds & seeds

Sesame, chia, almonds

Tahini

• Concentrated plant-based source of calcium

The core supplement stack

While food comes first, a targeted supplement protocol addresses the nutrient deficiencies that are almost universal in people with low BMD. These work synergistically — they are not optional extras.

Vitamin D3

• 2,000–5,000 IU daily
• Test first; target serum level 40–60 ng/mL. Without D3, dietary calcium absorption collapses.

Vitamin K2 (MK-7)

• 100–200 mcg daily
• Activates osteocalcin, directing calcium into bone rather than arterial walls. Critical partner to D3 — and the key nutrient that mitigates the soft-tissue deposition risk of excess calcium.

Magnesium glycinate

• 200–400 mg daily
• 50% of the body's magnesium is stored in bone. Also required for vitamin D conversion. Most people are deficient.

Strontium citrate

• 340–680 mg daily
• Structurally mimics calcium and incorporates into bone mineral. Stimulates osteoblasts and inhibits osteoclasts. Take separately from calcium-rich meals by several hours. Note: can slightly inflate DEXA readings.

Creatine monohydrate

• 3–5 g daily
• Enhances energy availability of osteoblasts, supporting their proliferation and activity. Studies show creatine combined with resistance training produces significantly greater BMD gains than exercise alone — particularly at the hip and lumbar spine. Also reduces fall risk through muscle preservation.

Collagen peptides: building the bone matrix

Bone is not just mineral — approximately 30% of bone is organic matrix, made predominantly of Type I collagen. This collagen scaffold is what minerals crystallize onto. Without an intact matrix, mineralization has nowhere to go. This is why targeted collagen peptide supplementation has emerged as a meaningful intervention for osteopenia.

Not all collagen supplements are equivalent. Generic hydrolyzed collagen provides amino acids, but clinically studied bioactive collagen peptides deliver specific peptide sequences that act as signaling molecules — telling osteoblasts to build and osteoclasts to slow down.

FORTIBONE (Gelita) — The most clinically relevant collagen peptide for bone. In randomized controlled trials in postmenopausal women with osteopenia, FORTIBONE at 5g/day significantly increased BMD, stimulated osteoblast activity, and inhibited osteoclast-driven resorption. Look for products that list FORTIBONE specifically on the label.

VERISOL (Gelita) — Primarily studied for skin and connective tissue, VERISOL supports the broader collagen matrix that underpins musculoskeletal integrity, complementing FORTIBONE in a full protocol.

Take 5–10g of collagen peptides daily with vitamin C (a required cofactor for collagen synthesis) alongside your D3/K2 stack for synergistic effect.

Peptide therapies for bone remodeling

Beyond collagen peptides, bioactive peptides represent one of the most exciting frontiers in functional medicine for bone health. These peptides work through distinct mechanisms — from direct tissue repair to stimulating the body's own growth hormone axis — and can be layered into a comprehensive protocol under clinical guidance.

Regenerative

• BPC-157
• Body protection compound; supports collagen synthesis, bone healing, and angiogenesis — the formation of new blood vessels that nourish bone tissue and support remodeling.

Repair

• TB-500 (Thymosin Beta-4)
• Promotes cellular repair and regeneration; supports the bone remodeling cycle via tissue repair pathways and systemic anti-inflammatory action.

Growth hormone secretagogues

Growth hormone (GH) plays a direct anabolic role in bone — stimulating osteoblast proliferation, increasing IGF-1 (which drives bone formation), and supporting the collagen matrix. GH declines significantly with age, and this decline contributes meaningfully to age-related bone loss. Growth hormone secretagogues are peptides that stimulate the pituitary to produce and release the body's own GH — a more physiologically nuanced approach than exogenous GH administration.

GH secretagogue

CJC-1295 / Ipamorelin

The most widely used secretagogue combination. CJC-1295 is a GHRH analog that extends the GH pulse; Ipamorelin is a selective GHRP that amplifies it without spiking cortisol or prolactin. Together they produce sustained, physiologic GH elevation — supporting bone formation, lean mass, and recovery. Typically administered via subcutaneous injection at night to align with natural GH rhythms.

Sermorelin

A truncated analog of GHRH that stimulates pulsatile GH release from the pituitary. One of the most studied and longest-used secretagogues, with a well-established safety profile. Particularly relevant for older adults where GH axis decline is most pronounced. Supports bone density, collagen synthesis, and body composition through downstream IGF-1 elevation.

Growth hormone secretagogues are prescription therapies requiring clinical oversight. Labs including IGF-1, fasting glucose, and HbA1c should be monitored, as GH elevation can influence insulin sensitivity. When appropriately dosed and monitored, these peptides represent a powerful anabolic addition to a bone-protective protocol.

 

HRT and bone mineral density

Estrogen is one of the most important regulators of bone resorption in the body. When estrogen declines — as in perimenopause and post-menopause — osteoclast activity accelerates, and bone loss can occur rapidly. This is why postmenopausal women carry a disproportionate share of osteopenia and osteoporosis diagnoses.

Hormone replacement therapy (HRT) has well-established, robust evidence for both preserving and meaningfully improving BMD. Studies consistently show that estrogen therapy reduces bone resorption markers, slows DEXA-measured bone loss, and significantly reduces fracture risk — particularly at the hip and spine.

"For perimenopausal and postmenopausal women with osteopenia, HRT deserves serious consideration as part of a bone-protective protocol."

Testosterone also plays a significant, often overlooked role in bone density in both men and women. In men, declining testosterone is a primary driver of age-related bone loss. In women, testosterone contributes to bone formation through androgen receptors in osteoblasts, and its decline in perimenopause compounds the effect of falling estrogen.

HRT decisions are highly individual and should be made in consultation with a physician who can assess cardiovascular risk, symptom burden, timing of menopause, and the type and route of hormone administration. Transdermal estrogen, for example, carries a more favorable risk profile than oral formulations.

 

What to avoid

Equally important as what you add is what you reduce. Excess caffeine, alcohol, smoking, and high-sodium processed foods all increase urinary calcium excretion — quietly leaching the minerals you're working to retain. Chronic stress elevates cortisol, which suppresses bone formation and accelerates resorption. A bone-protective lifestyle addresses these depleting factors as seriously as it addresses supplementation.

 

Putting it together

Reversing osteopenia is a multi-front effort. The most effective protocols combine mechanical loading through exercise, dietary calcium from whole foods — especially bony fish like sardines and anchovies — a synergistic core supplement stack of D3, K2, magnesium, strontium citrate, and creatine monohydrate, targeted collagen peptides (specifically FORTIBONE and VERISOL), regenerative peptides like BPC-157 and TB-500, growth hormone support through secretagogues such as CJC-1295/Ipamorelin or Sermorelin, and — where appropriate — hormonal support through HRT.

Track progress with annual DEXA scans and blood markers including 25-OH vitamin D, IGF-1, osteocalcin, and urine NTX (collagen breakdown in the urine to assess for bone resorption/loss). Bone density responds slowly — meaningful change takes 12 to 24 months of consistent effort. But the biology is on your side: bone is always remodeling, always capable of responding to the right inputs.

This article is for informational and educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before beginning any new supplement, peptide, or hormone therapy protocol. Individual results vary and interventions should be personalized to your health history and lab values.